Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure? (Q74779977)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

W A Gattis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

R L Larsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

V Hasselblad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

B A Bart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

C M O'Connor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

language of work or name

English

0 references

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

43-48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

The epidemiology of heart failure: the Framingham Study

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Quinapril in chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Current controversies with ACE inhibitor treatment in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970180-2

10.1016/S0002-8703(98)70180-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9665217%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference